Clinical trials - Press Releases

Date	Title	Company
10-Jan-2020	Glauconix Biosciences Promotes Kimberly Southern to the Position of Chief Executive Officer	Glauconix Biosciences Inc
10-Jan-2020	Galen, an Almac Group Company, Announces Completion of Multi-Million Pound POA Pharma Acquisition	Almac Group
10-Jan-2020	ProBioGen Inks Next Commercial GlymaxX® License with Roche	ProBioGen
10-Jan-2020	BC Platforms Partners with Dante Labs to build Europe’s largest Next Generation Sequencing laboratory for private and public customers	BC Platforms
10-Jan-2020	HUMMINGBIRD BIOSCIENCE PUBLISHES PRECLINICAL DATA DEMONSTRATING EFFICACY OF HMBD-001 IN HER3 DRIVEN CANCERS	Hummingbird Bioscience
10-Jan-2020	NANOBIOTIX ANNOUNCES PLAN FOR GLOBAL PHASE III HEAD AND NECK CANCER REGISTRATION TRIAL ALONG WITH OVERALL DEVELOPMENT UPDATE	NANOBIOTIX
10-Jan-2020	Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio	Calibre Scientific
10-Jan-2020	SOTIO Opens Office in Basel, Switzerland, to Accelerate Development of its Pipeline Products	SOTIO
09-Jan-2020	Availability of the Pre-quarterly Results Communication	Sanofi
09-Jan-2020	Alderaan Biotechnology raises €18.5M in Series A from Advent France Biotechnology (AFB) and Medicxi	Alderaan Biotechnology
09-Jan-2020	Block Commodities strengthens its Scientific Advisory Team (“SAT”) with two key appointments	Block Commodities Ltd
09-Jan-2020	Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology	Hikma Pharmaceuticals PLC
09-Jan-2020	China-based Green Valley’s Alzheimer’s drug Oligomannate set to capitalize on massive patient pool, says GlobalData	China's National Medical Products Administration (NMPA)
09-Jan-2020	Emergex raises more than US$11 million in a Series A Round to Progress its Pipeline of Set-point Vaccines for Infectious Diseases	EMERGEX VACCINES
09-Jan-2020	Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD	Minoryx Therapeutics
09-Jan-2020	Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases	Almirall
08-Jan-2020	Almirall enters into an option agreement to acquire Bioniz Therapeutics and to establish a broad research agreement to further expand its innovative pipeline in medical dermatology	Almirall
08-Jan-2020	Impact of the ATTC Network after 18 months of operation	Advanced Therapy Treatment Centre (ATTC)
07-Jan-2020	Litera and Yseop partner to fast-track regulation submission processes for Life Sciences companies	Litera Microsystems
07-Jan-2020	Innovative Cellular Therapeutics Appoints Cell and Gene Therapy Manufacturing Expert Christopher Ballas, Ph.D., as SVP of Manufacturing	Innovative Cellular Therapeutics